Study of Mogamulizumab With DA-EPOCH in Patients With Aggressive T Cell Lymphoma
Condition: T Cell Lymphoma Interventions: Drug: Mogamulizumab; Drug: DA-EPOCH Protocol Sponsors: Tarsheen Sethi; Kyowa Kirin, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 18, 2023 Category: Research Source Type: clinical trials
Low-dose Chidamide Maintenance Therapy After Allo-HSCT for T-cell Acute Lymphoblastic Leukemia or T-cell Lymphomas
Condition: T Lymphoblastic Leukemia/Lymphoma Intervention: Drug: Chidamide Sponsor: Zhejiang University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 15, 2023 Category: Research Source Type: clinical trials